Datadog Inc vs GeneDx Holdings Corp — how do they compare? Datadog Inc trades at $239.98 (market cap $88.61B), while GeneDx Holdings Corp trades at $81.93 (market cap $2.44B). The key difference: Datadog Inc is far larger — about 36.3× GeneDx Holdings Corp's market cap, and Datadog Inc is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| DDOG | WGS | |
|---|---|---|
Market Cap | $88.61B | $2.44B |
Sector | Technology | Technology |
52-Week High | $288.15 | $167.51 |
52-Week Low | $102.62 | $34.51 |
Enterprise Value | $84.90B | $2.48B |
Signals from Pluang's Aura AI — not financial advice
Datadog (DDOG) trades at $244.2, down 6.36% over 24 hours, with a bearish technical signal despite strong Q2 2026 earnings beats and raised full-year guidance. Revenue grew 36% year-over-year to $1.12 billion, but the stock faces pressure from high valuations (P/E 493.56) and concerns over a major customer's reduced usage. Analyst consensus remains strongly bullish with an 83.34% buy rating and a $288.55 price target, suggesting significant upside potential from current levels.
The outlook is mixed: robust fundamentals and AI-driven growth support long-term value, but near-term volatility persists due to premium valuation and investor skepticism post-earnings. Key risks include customer concentration, competitive pressures, and execution challenges in sustaining high growth rates. Investors should weigh strong analyst conviction against technical weakness and market sentiment shifts.
GeneDx Holdings Corp (WGS) trades at $82.07, up 5.38% in the past 24 hours, with technical indicators showing a bullish trend. The stock beat Q2 2026 EPS estimates but reported negative net income margins. Recent news highlights product expansion and institutional buying interest, though class-action lawsuits pose near-term sentiment risks.
Outlook is mixed: strong analyst buy ratings (90.9%) and a $79.25 consensus target suggest upside, but high valuation multiples and persistent losses require caution. Key risks include profitability challenges and legal overhangs, while revenue growth and market positioning offer long-term potential.
Trailing returns across standard periods
Latest headlines on both assets
Datadog is a cloud-native company that focuses on analyzing machine data. The firm's product portfolio, delivered as software-as-a-service, allows a client to monitor and analyze its entire IT infrastructure. Datadog's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to utilize it for a variety of different applications throughout their businesses.
Read more on DDOG →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →